What Happened To Biohaven Pharmaceuticals
What happened to Biohaven Pharmaceuticals? Biohaven and the new BHVN stock went public in early October after Pfizer finished buying its predecessor, known as Biohaven Pharmaceuticals. With the acquisition, Pfizer got Nurtec, two later-stage experimental migraine treatments and earlier-stage drugs targeting the same migraine-tied peptide. Did Pfizer buy Biohaven pharmaceuticals? Pfizer acquired all of the […]
What Happened To Biohaven Pharmaceuticals Read More »